SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Twin Vee PowerCats Co. engages in the design, manufacture, and sale of recreational and commercial power catamaran boats. The firm is focused on designing and developing its products under the ELECTRA Power Sports brand. It operates through the Twin Vee PowerCats and Wizz Banger, Inc. Segments. The Twin Vee PowerCats segment designs, manufactures, and sells recreational and commercial powerboats. The Wizz Banger, Inc. segment refers to a development-stage subsidiary with plans to develop an innovative online marketplace leveraging artificial intelligence (AI) to transform how customers search for and purchase recreational marine assets. The company was founded by Roger Dunshee in 1996 and is headquartered in Fort Pierce, FL.

Twin Vee PowerCats Co

Twin Vee PowerCats is seeing significant retail interest driven by its ultra-low micro-float status and momentum following a reverse stock split. The community is actively discussing the stock's squeeze potential, drawing comparisons to other high-volatility runners and pointing to recent insider buying as a catalyst for a potential parabolic move.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is experiencing significant volatility as investors weigh a strong earnings beat and market share expansion against concerns over margin pressure and competitive headwinds. The community remains deeply divided, with many long-term holders pointing to institutional manipulation and options pinning as the reasons for the disconnect between robust fundamentals and depressed share prices.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is experiencing a volatile surge driven by intense retail and institutional momentum, as traders draw parallels to the recent multi-week squeezes in larger memory sector peers. Investors are actively discussing the stock's potential as a low-float, high-upside play within the Edge AI and defense-infrastructure space, with many anticipating further upside despite discussions regarding legal challenges and valuation.

Applied Digital Corporation

Applied Digital is trending as investors capitalize on massive AI infrastructure expansion and institutional interest, with the community actively debating whether to hold through potential volatility or lock in gains. Traders are closely monitoring upcoming sector earnings for potential ripple effects, while long-term shareholders remain focused on the company's substantial contracted lease pipeline.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following a positive FDA pre-BLA meeting that validated its regulatory pathway for sonelokimab in hidradenitis suppurativa, fueling community excitement over a potential best-in-class label and expedited timeline. Investors are actively discussing upcoming clinical readouts, including 52-week trial data and adolescent-specific results, which many believe will force a major valuation re-rating and solidify the company as a prime acquisition candidate.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

The iShares Silver Trust is capturing significant investor attention as market participants debate whether silver is entering a long-term breakout cycle driven by rising industrial demand and supply chain concerns. Community sentiment is deeply divided, with many traders actively discussing potential short squeezes and hedging strategies while others remain skeptical about the sustainability of current price action amidst broader macroeconomic volatility.

e.l.f. Beauty, Inc. is a holding company, which engages in the provision of inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The company focuses on the e-commerce, national retailers and international business channels. Its brands include elf, elf skin, naturium, well people, and keys soulcare. The company was founded in 2004 and is headquartered in Oakland, CA.

e.l.f. Beauty Inc

e.l.f. Beauty is experiencing high volatility as investors weigh the positive implications of potential tariff relief against ongoing concerns about supply chain risks and geopolitical tensions. The community is actively debating the stock's valuation, with many bullish participants viewing recent price dips as a generational buying opportunity while others express frustration over inconsistent short-term price action and manipulation fears.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors debate the timing of long-awaited Phase 3 data for its leukemia candidate, with the community actively split between concerns over trial delays and optimism regarding potential curative efficacy and institutional positioning. The core discussion centers on the lack of an announced 80th event as a sign of durable patient survival versus frustration over the companys silence and repeated requests for stock-based compensation.

Odysight.ai, Inc. engages in the development and manufacture of customized visual solutions for organizations across a variety of industries in the form of micro cameras and supplementary technologies. Its devices can used across the medical, aerospace, industrial, research, and defense industries. The company was founded on March 22, 2013 and is headquartered in Omer, Israel.

Odysight.ai Inc

Odysight.AI Inc

Odysight.AI is currently capturing significant community attention following a cooperative research agreement with the U.S. Navy for AI-driven visual sensing technology. While bulls are excited by the potential for defense-sector growth and momentum, many traders are actively debating the sustainability of the price action and expressing skepticism regarding corporate dilution and past performance.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is facing heightened volatility and selling pressure following a revenue guidance miss, as investors weigh strong earnings beats against broader concerns regarding AI disruption in the enterprise SaaS sector. While many community members view the sharp price drop as a disconnect from the company's growth and cash-rich balance sheet, others remain cautious, debating whether established software platforms can effectively pivot or if they are vulnerable to emerging agentic AI competition.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Beats Revenue Estimates

The Oncology Institute (TOI) delivered earnings and revenue surprises of +71.43% and +1.54%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

IceCure Showcases ProSense Cryoablation at American Society of Breast Surgeons 2026 Annual Meeting as Commercial Momentum Accelerates in the U.S. Market

IceCure Showcases ProSense Cryoablation at American Society of Breast Surgeons 2026 Annual Meeting as Commercial Momentum Accelerates in the U.S. Market IceCure Showcases ProSense Cryoablation at...

IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025

IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025 IceCure Participates in Society...

IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement

IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private...

IceCure Medical Reports Positive Trial Results For ProSense Cryoablation System

(RTTNews) - IceCure Medical Ltd. (ICCM) on Wednesday, has reported favorable top-line results from its ICESECRET clinical trial, which assessed the ProSense Cryoablation System for the treatment of...

IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates

IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates IceCure Reports Positive 5-Year Top-Line Results from ICESECRET...

IceCure Medical Appoints Meir Peleg As CFO; Shares Rise In Pre-market

(RTTNews) - IceCure Medical Ltd. (ICCM), on Tuesday, appointed Meir Peleg as Chief Financial Officer, effective May 17...

IceCure Appoints Meir Peleg as Chief Financial Officer

IceCure Appoints Meir Peleg as Chief Financial Officer IceCure Appoints Meir Peleg as Chief Financial Officer PR Newswire CAESAREA, Israel, March 24, 2026 Meir Peleg brings over 20 years of financial...

IceCure Medical (ICCM) Q4 2025 Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

IceCure Reports 2025 Full Year Financial & Operational Results

IceCure Reports 2025 Full Year Financial & Operational Results IceCure Reports 2025 Full Year Financial & Operational Results PR Newswire CAESAREA, Israel, March 17, 2026 Record 4th quarter and full...

IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. Its product, ProSense Cryoablation System, provides invasive treatment option to destroy tumors by freezing them. The company was founded in 2006 and is headquartered in Caesarea, Israel.

Current Price	$0.2405
Prev Close	$0.24
Open	$0.2464
Dividend Yield	0.00%
50-Day Moving Average	$0.4372
Beta	0.93
Avg. Volume	535,468.20
PE Ratio	-1.02

52-Week High	$1.40
52-Week Low	$0.2375
Market Capitalization	$16.49M
EPS (Annual)	-$0.2368
Price to Book	1.94
Revenue Per Employee	$48,971.01

ICCM
Icecure Medical Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ICCM News

ICCMIcecure Medical Ltd